Clinical Trial Update: Pseudodrynaria Coronana (Wall) Ching [Phase 1]

View source ↗

Summary

Phase 1 trial of Pseudodrynaria coronana extract for osteoporosis has completed, with sponsor National Taiwan University Hospital reporting results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Pseudodrynaria Coronana extract (Pseudodrynaria coronana extract)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED